Correlation Between Tscan Therapeutics and 842400HF3

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and 842400HF3 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and 842400HF3 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and EIX 365 01 JUN 51, you can compare the effects of market volatilities on Tscan Therapeutics and 842400HF3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of 842400HF3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and 842400HF3.

Diversification Opportunities for Tscan Therapeutics and 842400HF3

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tscan and 842400HF3 is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and EIX 365 01 JUN 51 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EIX 365 01 and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with 842400HF3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EIX 365 01 has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and 842400HF3 go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and 842400HF3

Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 2.01 times more return on investment than 842400HF3. However, Tscan Therapeutics is 2.01 times more volatile than EIX 365 01 JUN 51. It trades about -0.04 of its potential returns per unit of risk. EIX 365 01 JUN 51 is currently generating about -0.12 per unit of risk. If you would invest  508.00  in Tscan Therapeutics on September 3, 2024 and sell it today you would lose (31.00) from holding Tscan Therapeutics or give up 6.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy30.0%
ValuesDaily Returns

Tscan Therapeutics  vs.  EIX 365 01 JUN 51

 Performance 
       Timeline  
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
EIX 365 01 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days EIX 365 01 JUN 51 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for EIX 365 01 JUN 51 investors.

Tscan Therapeutics and 842400HF3 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tscan Therapeutics and 842400HF3

The main advantage of trading using opposite Tscan Therapeutics and 842400HF3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, 842400HF3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 842400HF3 will offset losses from the drop in 842400HF3's long position.
The idea behind Tscan Therapeutics and EIX 365 01 JUN 51 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes